Management Committee
|
Stefan Borgas
|
Chief Executive Officer
|
|---|
|
Uwe H. Böhlke
|
Chief Officer Human Resources / Corporate Services
| |
Stephan Kutzer
|
COO Custom Manufacturing division
| |
Lukas Utiger
|
COO Life Science Ingredients division
| |
Anja Fiedler
|
COO Bioscience division
| |
Toralf Haag
|
Chief Financial Officer
|
Divisions
|
Custom Manufacturing (formerly Exclusive Synthesis & Biopharmaceutcals)
| |
Life Science Ingredients
| |
Bioscience
|
Group Functions
|
Global HR / Corporate Services
|
Legal
|
Corporate Development
|
Corporate Communications
|
Formulated Products
|
|
Key figures (million CHF)
|
2008
|
2009
|
2009
|
|---|
|
|
|
before special charges
|
after special charges 1
| |
Net sales
|
2937
|
2690
|
2690
| |
Operating income
|
441
|
380
|
239
| |
Net income
|
419
|
279
|
159
| |
Cash flow before change in net working capital
|
530
|
472
|
468
| |
Net debt
|
1469
|
1166
|
1166
| |
Investments in property, plant and equipment
|
420*
|
511*
|
511*
| |
Number of employees
|
8462
|
8386
|
8386
|
*excluding customer financial
1Special charges:
- Impairment of assets (83)
- Write-down of inventories (22)
- Restructuring expenses (25)
- Environmental expenses (11)
- Total special charges (141)
|
|
Sales by operating segments (million CHF)
|
2008
|
2009
|
|---|
|
Custom Manufacturing
|
1512
|
1418
| |
Life Science Ingredients
|
1196
|
1038
| |
Bioscience
|
222
|
231
| |
Corporate
|
|
3
|
|
|
